Immunogenetics of prostate cancer and benign hyperplasia – The potential use of an hla-g variant as a tag snp for prostate cancer risk

HLA

Volumn 87, Issue 2, 2016, Pages 79-88

  Zambra, F M B ^a   Biolchi, V ^b   De Cerqueira, C C S ^c   Brum, I S ^a   Castelli, E C ^d   Chies, J A B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b CENTRO UNIVERSITÁRIO UNIVATES   (Brazil)

^c CENTRO NACIONAL PATAGÓNICO   (Argentina)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

+3003 locus; 3 untranslated region; Benign prostatic hyperplasia; Haplotype; Prostate cancer; Untranslated region 4

Indexed keywords

DNA; HLA G ANTIGEN; 3' UNTRANSLATED REGION; TUMOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; BRAZILIAN; CASE CONTROL STUDY; CONTROLLED STUDY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOGENETICS; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; MIDDLE AGED; PROSTATE TUMOR; VERY ELDERLY;

3' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENOTYPE; HLA-G ANTIGENS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 85010727680     PISSN: 20592302     EISSN: 20592310     Source Type: Journal    
DOI: 10.1111/tan.12741     Document Type: Article

References (48)

1. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC. CancerBase No. 11 [Internet]. International Agency for Research on Cancer;Lyon, France, 2013. Available at: http://globocan.iarc.fr (accessed on 01 February 2016).
2. Gronberg H. Prostate cancer epidemiology. Lancet 2003: 361: 859–64.
3. Miller AM, Pisa P. Tumor escape mechanisms in prostate cancer. Cancer Immunol Immunother 2007: 56: 81–7.
4. Rajarubendra N, Lawrentschuk N, Bolton DM, Klotz L, Davis ID. Prostate cancer immunology – an update for Urologists. BJU Int 2011: 107: 1046–51.
5. Paul P, Rouas-Freiss N, Khalil-Daher I et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci U S A 1998: 95: 4510–5.
6. Amiot L, Ferrone S, Grosse-Wilde H, Seliger B. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cell Mol Life Sci 2011: 68: 417–31.
7. Carosella ED, Moreau P, LeMaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008: 29: 125–32.
8. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011: 68: 369–95.
9. Slovin S. Chemotherapy and immunotherapy combination in advanced prostate cancer. Clin Adv Hematol Oncol 2012: 10: 90–100.
10. Langat DK, Platt JS, Tawfik O, Fazleabas AT, Hunt JS. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma. J Reprod Immunol 2006: 71: 75–86.
11. Carosella ED, Rouas-Freiss N, Roux DT, Moreau P, LeMaoult J. HLA-G: an immune checkpoint molecule. Adv Immunol 2015: 127: 33–144.
12. ′ untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010: 11: 134–41.
13. Castelli EC, Veiga-Castelli LC, Yaghi L, Moreau P, Donadi EA. Transcriptional and posttranscriptional regulations of the HLA-G gene. J Immunol Res 2014: 2014: 734068.
14. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993: 2: 2200.
15. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001: 57: 15–21.
16. Hviid TVF, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003: 55: 63–79.
17. Hviid TVF, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004: 56: 135–41.
18. ′ untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression. Hum Immunol 2006: 67: 53–62.
19. Rizzo R, Bortolotti D, Ben Fredj N et al. Role of HLA-G 14 bp deletion/insertion and +3142C > G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Hum Immunol 2012: 73: 1140–6.
20. Tan Z, Randall G, Fan J et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007: 81: 829–34.
21. ′ untranslated region alleles and haplotypes. Hum Immunol 2009: 70: 1020–5.
22. Veit TD, Chies JAB. Tolerance versus immune response – MicroRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol 2009: 20: 229–31.
23. Nicodemus-Johnson J, Laxman B, Stern RK et al. Maternal asthma and microRNA regulation of soluble HLA-G in the airway. J Allergy Clin Immunol 2013: 131: 1496–503.
24. ′ -untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008: 14: 649–53.
25. Porto IOP, Mendes-Junior CT, Felicio LP et al. MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G. Mol Immunol 2015: 65: 230–41.
26. Osorio RG. O sistema classificatório de “cor ou raça” do IBGE. Brasília: Instituto de Pesquisa Econômica Aplicada, 2003, 50.
27. Zambra FMB, Biolchi V, Brum IS, Chies JAB. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer. Hum Immunol 2013: 74: 1003–8.
28. ′ UTR of the HLA-G gene are associated with septic shock in critically ill patients. Crit Care 2012: 16: R211.
29. Cordero EAA, Veit TD, da Silva MAL, Jacques SMC, Silla LMDR, Chies JAB. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009: 74: 308–13.
30. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005: 1: 47–50.
31. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992: 48: 361–72.
32. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995: 56: 799–810.
33. Long JC. Multiple Locus Haplotype Analysis, version 3.0. Software and documentation distributed by the author. Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 1999.
34. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001: 68: 978–89.
35. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003: 73: 1162–9.
36. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004: 1: 6.
37. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol 2011: 28: 3069–86.
38. Lucena-Silva N, Teixeira MA, Ramos Ade L et al. The +3187A/G HLA-G polymorphic site is associated with polar forms and reactive reaction in leprosy. Mol Genet Genomic Med 2013: 1: 123–30.
39. ′ untranslated region of the HLA-G gene are associated with differential HLA-G soluble levels in the Brazilian and French population. PLoS One 2013: 8: e71742.
40. Castelli EC, Ramalho J, Porto IOP et al. Insights into HLA-G genetics provided by worldwide haplotype diversity. Front Immunol 2014: 5: 476.
41. ′ untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes Immun 2014: 15: 95–106.
42. Santos KE, Lima THA, Felicio LP et al. Insights on the HLA-G evolutionary history provided by a nearby Alu insertion. Mol Biol Evol 2013: 30: 2423–34.
43. ′ untranslated region of the HLA-G gene in individuals from two different geographical regions of Brazil. Tissue Antigens 2012: 79: 272–8.
44. ′ untranslated region polymorphisms are associated with systemic lupus erythematosus in 2 Brazilian populations. J Rheumatol 2013: 40: 1104–13.
45. Carlini F, Traore K, Cherouat N et al. HLA-G UTR haplotype conservation in the Malian population: association with soluble HLA-G. PLoS One 2013: 8: e82517.
46. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G-725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006: 21: 1743–8.
47. Instituto Nacional de Cãncer José Alencar Gomes da Silva. Coordenação de Prevenção e Vigilãncia. Estimate/2014 – Cancer incidence in Brazil. Rio de Janeiro, INCA 2014: 124.
48. Marino-Enriquez A, Fletcher CDM. Shouldn’t we care about the biology of benign tumours? Nat Rev Cancer 2014: 14: 701–2.